Skip to main content

Table 1 Eligibility criteria

From: Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial

Inclusion criteria

Exclusion criteria

- Aged between 18 and 60 years

- Static disorders of the spine

- Low back pain with an inflammatory pattern (at least one of three characteristics: waking at night due to pain, morning stiffness for longer than 60 minutes, maximal pain on morning)

- Contraindication to pamidronate (hypocalcaemia, severe kidney failure or allergy)

- Underage patients, patients subject to legal protections

- Previous treatment with bisphosphonates

- Pregnancy

- Daily pain for at least three months

- VAS for pain > 40/100 in the last 48 hours

- Local or general infection

- Previous disc surgery

- Lack of efficacy, intolerance, or contraindication to NSAIDs

- Systemic corticosteroid therapy in the last month

- Lack of efficacy of a rigid or semi-rigid back brace

- Epidural or facet joint corticosteroid injection in the last month

- Modic 1 disc disease (diagnosed on MRI and confirmed by a trained radiologist)

- History of septic spondylodiscitis

- Dental check-up within the last six months

- Ankylosing spondylitis

- Low back pain associated with radiculalgia

- Signed informed consent form

- Active psychiatric disorder

- Inability to read or understand French

- Body temperature greater than 38°C (fever) or erythrocyte sedimentation rate greater than 20 mm/hour

  1. MRI, magnetic resonance imaging; NSAIDs, non-steroidal anti-inflammatory drugs; VAS, Visual Analogic Scale.